Opendata, web and dolomites

EpiShuttle 2.0 SIGNED

EpiShuttle: Isolation and Transportation of Infectious Disease Patients

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 EpiShuttle 2.0 project word cloud

Explore the words cloud of the EpiShuttle 2.0 project. It provides you a very rough idea of what is the project "EpiShuttle 2.0" about.

modern    combining    people    leap    virus    madagascar    professionals    diseases    expand    congo    resistant    global    wants    asia    cdc    regulatory    lives       least    isolate    disease    group    globally    care    economic    infected    founded    patient    health    plague    opportunity    launched    outside    faced    class    engineering    solution    position    patterns    specialized    investment    2014    world    11    worldwide    person    re    protection    pulmonary    sius    usa    ebola    company    larger    clearance    outbreaks    polycarbonate    doctors    market    medical    infectious    bill    mers    transport    units    china    africa    12    risk    handle    drc    size    compromising    epishuttle    representing    events    risks    team    patients    demonstrated    plus    emergency    eur    workflow    manner    travelling    epidemic    2015    isolation    epiguard    siu    disinfection    claimed    first    tuberculosis    77    thousand    zika    gas    society    labour    west    reusable    hard    positive    standard    capital    recommends    security    sars    treatment    complete    catastrophe    partnering    million    gold    brazil    contagious   

Project "EpiShuttle 2.0" data sheet

The following table provides information about the project.

Coordinator
EPIGUARD AS 

Organization address
address: TORSNESVEIEN 210
city: GAMLE FREDRIKSTAD
postcode: 1634
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Norway [NO]
 Total cost 3˙565˙000 €
 EC max contribution 2˙495˙500 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2021-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    EPIGUARD AS NO (GAMLE FREDRIKSTAD) coordinator 2˙495˙500.00

Map

 Project objective

The Problem: An increasing number of outbreaks with infectious diseases are seen globally. Ebola has claimed at least 77 lives in DRC (Congo) so far this year and over 11 thousand people West Africa in 2014. Other recent outbreaks are the SARS-epidemic, the MERS-cases in Asia, multi-resistant tuberculosis and the pulmonary Plague epidemic in Madagascar, Zika virus in Brazil, etc. Each of these events demonstrated the large health, economic and security risks associated with infectious disease outbreaks. The travelling patterns of our modern society increases the risk of a global “catastrophe”. To handle outbreaks, the CDC highly recommends the use of specialized isolation units (SIU) to isolate and transport the infected patients. The Solution: EpiGuard was founded in 2015 by a group of medical doctors that faced the challenge of managing Ebola patients on the field. After 3 years and ~5 million EUR of capital and labour investment, the company has recently launched into EU market the EpiShuttle solution – the world-first hard-top (polycarbonate), reusable SIU, representing a leap forward against the state of the art. The EpiShuttle is a one-person SIU, providing complete protection from contagious diseases, without compromising advanced treatment and care to the patient. The Opportunity: Partnering with a world-class design and engineering team, EpiGuard wants to position EpiShuttle as the gold standard for SIUs in the emergency workflow. EpiShuttle targets a 12 Bill. EUR market opportunity worldwide. Although the response from medical professionals has been positive, to fully exploit the market potential, there is a need for combining modern gas disinfection technology with EpiShuttle to allow re-use in a cost effective manner. Further, to expand the market outside Europe, regulatory clearance in USA and China plus a larger size unit for the USA market are needed.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EPISHUTTLE 2.0" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EPISHUTTLE 2.0" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

APS (2019)

On-site and On-demand Flexible Packaging System

Read More